DNMT3A and neoplasm: According to public databases, our data strongly suggest CDK6, DNMT3A and DNMT3B as direct targets of miR-29a-3p: disallowed tumor-suppressive function of this miRNA may stimulate tumorigenesis by promoting cell cycle progression and altering de novo methylation of the genome.